EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic mutations in Parkinson’s disease: screening of a selected population from North-Eastern Italy

Giulia Bonato, Angelo Antonini, Francesca Pistonesi, Marta Campagnolo, Andrea Guerra, Roberta Biundo, Manuela Pilleri, Cinzia Bertolin, Leonardo Salviati, Miryam Carecchio

Neurological Sciences · 2025-01 · 46 (1) · 165-174

DOI: 10.1007/s10072-024-07690-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurological Sciences, online erschienen am 22.07.2024. Verfasst von Giulia Bonato und 9 weiteren Autor:innen. Beteiligte Einrichtung: Parkinson and Movement Disorders Unit, Centre for Rare Neurological Diseases (ERN-RND), Department of Neuroscience, University of Padova, Via Giustin…. Hauptthemen laut MEDLINE: Parkinson Disease, Mutation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Padova.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson’s disease (PD) is a progressive neurodegenerative disorder with a multifactorial pathogenesis. Several genetic variants increase the risk of PD and about 5–10% of cases are monogenic. This study aims to define the genetic bases and clinical features of PD in a cohort of patients from Northeastern Italy, a peculiar geographical area previously not included in genetic screenings.

Methods

Using an NGS multigenic panel, 218 PD patients were tested based on age at onset, family history and development of atypical features.

Results

A total of 133 genetic variants were found in 103 patients. Monogenic PD was diagnosed in 43 patients (20% of the cohort); 28 (12.8%) carried mutations in GBA1 , 10 in LRRK2 (4.6%) and 5 in PRKN (2.3%). In 17% of patients the genetic defect remained of uncertain interpretation. The selection criterion “age of onset < 55 years” was a significant predictor of a positive genetic test (OR 3.8, p 0.0037). GBA1 patients showed more severe symptoms and a higher burden of motor and non-motor complications compared to negative patients (dyskinesias OR 3, sleep disturbances OR 2.8, cognitive deficits OR 3.6; p < 0.05), with greater autonomic dysfunction (COMPASS-31 score 34.1 vs 20.2, p 0.03).

Conclusions

Applying simple clinical criteria for genetic testing allows to increase the probability to identify patients with monogenic PD and better allocate resources. This process is critical to widen the understanding of disease mechanisms and to increase the individuation of patients potentially benefitting from future disease-modifying therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseMutationHumansItalyMaleFemaleMiddle AgedAgedGenetic TestingGlucosylceramidaseLeucine-Rich Repeat Serine-Threonine Protein Kinase-2Cohort StudiesAdultAge of OnsetAged, 80 and overUbiquitin-Protein LigasesGenetic Predisposition to Disease

Stichwörter der Autor:innen

GBAGeneticsNGSParkinson

Substanzen

GlucosylceramidaseGBA protein, humanLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humanparkin proteinUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Parkinson and Movement Disorders Unit, Centre for Rare Neurological Diseases (ERN-RND), Department of Neuroscience, University of Padova, Via Giustiniani 2, 35128, Padua, Italy.
  • Center for Neurodegenerative Disease Research (CESNE), University of Padova, Padua, Italy.
  • Department of General Psychology, University of Padova, Padua, Italy.
  • Parkinson Institute, ASST G. Pini-CTO, Milan, Italy.
  • Department of Woman and Children's Health, Genetic Unit, University of Padova, Padua, Italy.
  • Parkinson and Movement Disorders Unit, Centre for Rare Neurological Diseases (ERN-RND), Department of Neuroscience, University of Padova, Via Giustiniani 2, 35128, Padua, Italy. miryam.carecchio@unipd.it.

Förderung

  • Università degli Studi di Padova

Zitieren

APA

Bonato, G., Antonini, A., Pistonesi, F., Campagnolo, M., Guerra, A., Biundo, R., Pilleri, M., Bertolin, C., Salviati, L., & Carecchio, M. (2025). Genetic mutations in Parkinson’s disease: screening of a selected population from North-Eastern Italy. Neurological Sciences, 46(1), 165-174. https://doi.org/10.1007/s10072-024-07690-7

Vancouver

Bonato G, Antonini A, Pistonesi F, Campagnolo M, Guerra A, Biundo R, et al. Genetic mutations in Parkinson’s disease: screening of a selected population from North-Eastern Italy. Neurological Sciences. 2025;46(1):165-174. doi:10.1007/s10072-024-07690-7

BibTeX
@article{Bonato2025,
  author = {Bonato, Giulia and Antonini, Angelo and Pistonesi, Francesca and Campagnolo, Marta and Guerra, Andrea and Biundo, Roberta and Pilleri, Manuela and Bertolin, Cinzia and Salviati, Leonardo and Carecchio, Miryam},
  title = {Genetic mutations in Parkinson’s disease: screening of a selected population from North-Eastern Italy},
  journal = {Neurological Sciences},
  year = {2025},
  volume = {46},
  number = {1},
  pages = {165--174},
  doi = {10.1007/s10072-024-07690-7}
}
Kostenlos starten →